Research Paper Volume 4, Issue 6 pp 436—447
The Tellurium compound, AS101, increases SIRT1 level and activity and prevents type 2 diabetes
Figure 5. AS101 treatment protects rats from HFD+STZ induced hepatosteatosis. (A) Oil red staining of lipid droplets in frozen liver sections. Pictures represent two out of the six animals in each group. (B) AS101 treatment reduces serum ALP levels. (*p<0.05 decrease vs. diabetic group, n=6 in each group).